Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-19

Clinical Trial Update: Reduction of Elimination of Mitral Regurgitation With the SATURN TMVR System (CASSINI-US) [NA]

View source ↗

Summary

Clinical trial update on the SATURN TMVR System (CASSINI-US) for reducing mitral regurgitation; the study is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SATURN TMVR System

Snippet

Sponsor: InnovHeart | Conditions: Mitral Regurgitation, Heart Disease | NA | Status: NOT_YET_RECRUITING